VAERS reports by lot

Merck Pneumococcal lot U022984: VAERS reports

25 VAERS reports list lot U022984 as a Merck Pneumococcal vaccine, received between 2022-01-15 and 2023-10-31. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
25
Reports
0%
Marked serious
0
With a death outcome
16
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2246%
Musculoskeletal817%
Cardiac / Cardiovascular510%
Allergic / Anaphylactic48%
General / Systemic (non-local)48%
Neurological36%
Dermatological (non-injection-site)24%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida4
New York3
New Jersey2
Pennsylvania2
Arkansas1
South Carolina1
Hawaii1
Indiana1
North Carolina1
West Virginia1
Texas1
Minnesota1

Reports by month received

2022-011
2022-021
2022-031
2022-043
2022-051
2022-062
2022-072
2022-081
2022-102
2022-111
2023-011
2023-021
2023-035
2023-051
2023-071
2023-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.